Background The effect of gut microbiota dysbiosis on human metabolome and the potential
of microbial and endogenous metabolites as biomarkers of chronic intestinal inflammation …

Antibiotics strongly disrupt the human gut microbiota, which in consequence loses its
colonization resistance capacity, allowing infection by opportunistic pathogens such as …

Clostridium difficile infection (CDI) is a major source of morbidity and mortality for the US
health care system and frequently complicates the course of inflammatory bowel disease …

Fecal microbiota transplantation (FMT) is a promising therapy for Clostridium difficile
infection (CDI). However, questions remain regarding efficacy and safety in inflammatory …

The human gut microbiome is a complex ecosystem of fundamental importance to human
health. Our increased understanding of gut microbial composition and functional interactions …

Clostridium difficile infection (CDI) is principally responsible for hospital acquired, antibiotic-
induced diarrhea and colitis and represents a significant financial burden on our healthcare …

Many cases of Clostridioides difficile infection (CDI) are poorly responsive to standard
antibiotic treatment strategies, and often patients suffer from recurrent infections …

Background & Aims Inflammatory bowel disease (IBD) is a widespread gastrointestinal
inflammatory disorder with globally increasing incidence. Clostridioides difficile infection …

Background Alterations in the fecal bacterial flora occur in inflammatory bowel disease
(IBD). We examined the abundance and diversity of Clostridium leptum group, an important …

The human gut is a complex microbial ecosystem comprising approximately 100 trillion
microbes collectively known as the “gut microbiota”. At a rough estimate, the human gut …